TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Danaher ( (DHR) ) has provided an announcement.
On September 9, 2025, Danaher Corporation’s Board of Directors revised the company’s By-laws to update procedural and disclosure requirements for shareholder proposals and director nominations. Additionally, the Board approved a new share repurchase program authorizing the buyback of up to 35 million shares of common stock, with no expiration date, allowing management to decide on timing and amount based on market conditions.
The most recent analyst rating on (DHR) stock is a Buy with a $241.00 price target. To see the full list of analyst forecasts on Danaher stock, see the DHR Stock Forecast page.
Spark’s Take on DHR Stock
According to Spark, TipRanks’ AI Analyst, DHR is a Neutral.
Danaher’s overall stock score is driven by its strong financial performance and positive earnings call insights, highlighting robust growth in key segments. However, high valuation metrics and neutral technical indicators temper the score, with challenges in revenue growth and global trade tensions posing risks.
To see Spark’s full report on DHR stock, click here.
More about Danaher
Danaher Corporation operates in the industrial and life sciences sectors, providing a wide range of products and services including diagnostic equipment, environmental and applied solutions, and dental products. The company focuses on innovation and operational excellence to maintain its market position.
Average Trading Volume: 3,844,536
Technical Sentiment Signal: Sell
Current Market Cap: $142.2B
Learn more about DHR stock on TipRanks’ Stock Analysis page.